An otherwise negative trial may have identified a subgroup of patients likely to respond well to this potential transcatheter therapy for heart failure.
The hidden link between inflammation and disease harvard.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from harvard.edu Daily Mail and Mail on Sunday newspapers.
Were the GLP-1 receptor agonist drug s apparent benefits in STEP-HFpEF due solely to weight loss or additional mechanisms? The trial offers a clue, experts say.
Four experts explain nuances of the multidrug strategy and why it should be easy to implement. Given its slow uptake in practice, what forces are conspiring against it?